VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Julius Baer Gruppe AG vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Julius Baer Gruppe AG
BAER · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Julius Baer Gruppe AG's moat claims, evidence, and risks.
View BAER analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 59 / 100 for Julius Baer Gruppe AG).
- Segment focus: Julius Baer Gruppe AG has 1 segment (100% in Wealth Management (Private Banking)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Julius Baer Gruppe AG has 5 moat types across 4 domains; Sanofi has 5 across 3.
Primary market context
Julius Baer Gruppe AG
Wealth Management (Private Banking)
Private banking and wealth management services
Global (focus: Switzerland, Europe, Asia)
High-net-worth and ultra-high-net-worth individuals
Wealth manager / private bank (advisory + discretionary mandates)
100%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Julius Baer Gruppe AG strengths
Sanofi strengths
Segment mix
Julius Baer Gruppe AG segments
Full profile >Wealth Management (Private Banking)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.